Affiliation:
1. Clinical Microbiology Institute, Tualatin, Oregon 97062.
Abstract
For testing bacterial susceptibility to PD131628, a 5-micrograms disk and the following tentative interpretive criteria may be used: > or = 19 mm for susceptible (MIC, < or = 1.0 micrograms/ml), 16 to 18 mm for intermediate (MIC, 2.0 micrograms/ml), and < or = 15 mm for resistant (MIC, > or = 4.0 micrograms/ml). For standard quality control strains, the following limits are proposed: for Escherichia coli ATCC 25922, zones of 31 to 41 mm or a MIC of 0.002 to 0.016 micrograms/ml; for Pseudomonas aeruginosa ATCC 27853, zones of 26 to 34 mm or a MIC of 0.12 to 0.5 micrograms/ml; for Staphylococcus aureus ATCC 25923, zones of 27 to 33 mm; for Staphylococcus aureus ATCC 29213, a MIC of 0.03 to 0.12 micrograms/ml; and for Enterococcus faecalis ATCC 29212, a MIC of 0.12 to 0.5 micrograms/ml.
Publisher
American Society for Microbiology
Reference12 articles.
1. Antimicrobial activity evaluation of two new quinolones, PD127,391 (CI-960 and AM-1091) and PD131628;Barrett H. S.;Diagn. Microbiol. Infect. Dis.,1991
2. Antistaphylococcal activity of the fluoroquinolones CI-960, PD131,628, sparfloxacin, ofloxacin, and ciprofloxacin;Barry A. L.;Eur. J. Clin. Microbiol. Infect. Dis.,1991
3. Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD131628 and clinafloxacin;Barry A. L.;J. Antimicrob. Chemother.,1993
4. In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent;Cohen M. A.;Antimicrob. Agents Chemother.,1991
5. In vitro activity of PD131628, a new quinolone antimicrobial agent;Cooper M. A.;J. Antimicrob. Chemother.,1992
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献